Filing Details

Accession Number:
0001144204-13-015174
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-14 19:00:44
Reporting Period:
2013-03-12
Filing Date:
2013-03-14
Accepted Time:
2013-03-14 19:00:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006281 Protalix Biotherapeutics Inc. PLX Biological Products, (No Disgnostic Substances) (2836) 650643773
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1434514 Alfred Akirov C/O Protalix Biotherapeutics, Inc.
2 Snunit Street, Science Park, Pob 455
Carmiel L3 20100
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-03-12 10,000 $5.70 5,027,713 No 4 S Indirect By Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Corporation
Footnotes
  1. All sales reported on this Form 4 were made by Alrov (Israel) Ltd.("Alrov Israel") and the column in Table 1 disclosing the amount of securities beneficially owned following the reported transaction includes 686,046 shares of our common stock held by Technorov Holdings (1993) Ltd. ("Technorov"). Alrov Israel owns 100% of Al-Rov Technologies Holdings LTD, the holder of 80% of Technorov. The reporting person is the Chairman of Alrov Israel and the Chief Executive Officer of Technorov, and has the power to control their respective investment decisions. Alrov Israel is an Israeli publicly-traded company that is listed on the Tel Aviv Stock Exchange. The reporting person disclaims beneficial ownership of the securities of the Issuer held by Alrov Israel and Technorov, except to the extent of his proportional pecuniary interest therein.